Silk Road Medical Quarterly Balance Sheets Chart
Quarterly
|
Annual
Silk Road Medical Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||
| cash and cash equivalents | 22,639,000 | 22,629,000 | 20,210,000 | 29,188,000 | 28,400,000 | 50,427,000 | 55,358,000 | 51,306,000 | 87,637,000 | 93,602,000 | 110,231,000 | 105,642,000 | 101,849,000 | 94,575,000 | 69,466,000 | 62,468,000 | 73,442,000 | 27,552,000 | 39,181,000 | 112,277,000 | 118,247,000 | 15,509,000 |
| short-term investments | 149,344,000 | 151,833,000 | 161,264,000 | 163,673,000 | 159,961,000 | 138,640,000 | 158,316,000 | 53,826,000 | 21,234,000 | 17,127,000 | 26,293,000 | 41,497,000 | 78,016,000 | 91,442,000 | 84,416,000 | 70,067,000 | 51,508,000 | |||||
| accounts receivable | 26,252,000 | 27,203,000 | 23,573,000 | 21,779,000 | 21,525,000 | 19,956,000 | 18,007,000 | 17,019,000 | 15,779,000 | 13,876,000 | 11,832,000 | 10,976,000 | 11,747,000 | 11,106,000 | 9,070,000 | 9,398,000 | 7,753,000 | 8,670,000 | 8,601,000 | 6,932,000 | 5,417,000 | 4,096,000 |
| inventories | 29,682,000 | 30,486,000 | 29,876,000 | 22,066,000 | 19,067,000 | 17,182,000 | 19,293,000 | 20,293,000 | 17,616,000 | 17,726,000 | 17,851,000 | 16,049,000 | 12,771,000 | 11,960,000 | 9,989,000 | 10,946,000 | 11,621,000 | 12,101,000 | 10,322,000 | 9,275,000 | 8,963,000 | 8,056,000 |
| prepaid expenses and other current assets | 13,104,000 | 3,543,000 | 5,912,000 | 4,277,000 | 4,543,000 | 4,049,000 | 3,924,000 | 4,543,000 | 4,653,000 | 2,564,000 | 3,412,000 | 4,662,000 | 5,877,000 | 4,757,000 | 6,787,000 | 3,443,000 | 3,863,000 | 1,894,000 | 2,878,000 | 3,503,000 | 3,249,000 | 1,391,000 |
| total current assets | 241,021,000 | 235,694,000 | 240,835,000 | 240,983,000 | 233,496,000 | 230,254,000 | 254,898,000 | 146,987,000 | 146,919,000 | 127,768,000 | 143,326,000 | 154,456,000 | 158,537,000 | 163,895,000 | 173,328,000 | 177,697,000 | 181,095,000 | 120,284,000 | 112,490,000 | 131,987,000 | 135,876,000 | 29,052,000 |
| long-term investments | 14,178,000 | 2,027,000 | 9,456,000 | 4,348,000 | 13,884,000 | 15,285,000 | 18,224,000 | |||||||||||||||
| property and equipment | 8,381,000 | 8,085,000 | 8,114,000 | 8,337,000 | 8,644,000 | 8,897,000 | 9,372,000 | 9,671,000 | 9,755,000 | 9,866,000 | 7,697,000 | 5,132,000 | 3,428,000 | 2,777,000 | 2,844,000 | 2,824,000 | 2,885,000 | 2,707,000 | 2,734,000 | 2,697,000 | 2,743,000 | 2,846,000 |
| other non-current assets | 6,227,000 | 6,508,000 | 6,904,000 | 7,196,000 | 7,336,000 | 4,996,000 | 5,260,000 | 5,731,000 | 5,815,000 | 5,134,000 | 5,370,000 | 5,711,000 | 5,931,000 | 2,680,000 | 2,832,000 | 2,997,000 | 3,233,000 | 3,444,000 | 3,644,000 | 3,575,000 | 3,723,000 | 6,460,000 |
| total assets | 269,807,000 | 252,314,000 | 265,309,000 | 260,864,000 | 263,360,000 | 259,587,000 | 269,685,000 | 162,544,000 | 162,721,000 | 143,000,000 | 156,625,000 | 165,531,000 | 168,206,000 | 169,662,000 | 179,314,000 | 183,828,000 | 187,523,000 | 126,745,000 | 137,402,000 | 138,569,000 | 142,652,000 | 38,668,000 |
| liabilities and stockholders' equity | ||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||
| accounts payable | 3,693,000 | 2,966,000 | 5,676,000 | 5,094,000 | 5,338,000 | 5,272,000 | 2,523,000 | 4,312,000 | 3,666,000 | 2,926,000 | 2,379,000 | 4,908,000 | 1,958,000 | 2,923,000 | 2,598,000 | 2,046,000 | 2,542,000 | 3,194,000 | 1,898,000 | 1,965,000 | 1,189,000 | 3,134,000 |
| accrued liabilities | 27,879,000 | 18,371,000 | 24,607,000 | 18,928,000 | 18,759,000 | 15,598,000 | 21,965,000 | 19,621,000 | 17,575,000 | 16,744,000 | 19,802,000 | 16,011,000 | 14,705,000 | 13,291,000 | 16,957,000 | 13,008,000 | 9,142,000 | 11,125,000 | 15,034,000 | 10,476,000 | 8,299,000 | 7,658,000 |
| total current liabilities | 31,572,000 | 21,337,000 | 30,283,000 | 24,022,000 | 24,097,000 | 20,870,000 | 24,488,000 | 23,933,000 | 21,241,000 | 29,499,000 | 26,086,000 | 20,919,000 | 16,663,000 | 16,214,000 | 19,555,000 | 15,054,000 | 11,684,000 | 14,319,000 | 16,932,000 | 12,441,000 | 9,488,000 | 10,792,000 |
| long-term debt | 76,147,000 | 75,886,000 | 75,626,000 | 75,364,000 | 75,104,000 | 74,848,000 | 74,596,000 | 74,340,000 | 74,033,000 | 38,901,000 | 44,786,000 | 48,652,000 | 48,614,000 | 48,574,000 | 48,533,000 | 45,160,000 | 45,066,000 | 44,972,000 | 44,879,000 | 44,785,000 | 44,690,000 | 44,597,000 |
| other liabilities | 7,404,000 | 7,806,000 | 8,249,000 | 8,336,000 | 8,654,000 | 6,256,000 | 6,726,000 | 7,073,000 | 7,418,000 | 6,893,000 | 6,513,000 | 7,781,000 | 6,791,000 | 3,720,000 | 3,726,000 | 3,876,000 | 3,693,000 | 3,497,000 | 3,700,000 | 3,900,000 | 4,097,000 | 4,285,000 |
| total liabilities | 115,123,000 | 105,029,000 | 114,158,000 | 107,722,000 | 107,855,000 | 101,974,000 | 105,810,000 | 105,346,000 | 102,692,000 | 75,293,000 | 77,385,000 | 77,352,000 | 72,068,000 | 68,508,000 | 71,814,000 | 64,090,000 | 60,443,000 | 62,788,000 | 65,511,000 | 61,126,000 | 58,275,000 | 91,477,000 |
| commitments and contingencies | ||||||||||||||||||||||
| stockholders' equity: | ||||||||||||||||||||||
| preferred stock, 0.001 par value | ||||||||||||||||||||||
| shares authorized: 5,000,000 at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||
| shares issued and outstanding: none at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||
| common stock | ||||||||||||||||||||||
| shares authorized: 100,000,000 at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||
| shares issued and outstanding: 40,612,481 and 39,165,481 at june 30, 2024 and december 31, 2023, respectively | 41,000 | |||||||||||||||||||||
| additional paid-in capital | 584,959,000 | 560,854,000 | 550,495,000 | 539,831,000 | 529,453,000 | 517,663,000 | 507,715,000 | 388,452,000 | 380,775,000 | 373,053,000 | 367,907,000 | 362,152,000 | 356,224,000 | 350,699,000 | 346,318,000 | 341,687,000 | 338,550,000 | 264,951,000 | 263,384,000 | 260,647,000 | 259,574,000 | 5,194,000 |
| accumulated other comprehensive income | -122,000 | -17,000 | 72,000 | 83,000 | -166,000 | -191,000 | -2,000 | 1,000 | 3,000 | 6,000 | 39,000 | 152,000 | 316,000 | 442,000 | 2,000 | |||||||
| accumulated deficit | -430,194,000 | -413,591,000 | -399,455,000 | -386,444,000 | -373,656,000 | -360,172,000 | -343,712,000 | -331,098,000 | -320,779,000 | -305,381,000 | -288,702,000 | -274,009,000 | -260,124,000 | -249,585,000 | -238,891,000 | -222,135,000 | -211,820,000 | -201,467,000 | -191,526,000 | -183,235,000 | -175,228,000 | -163,269,000 |
| total stockholders' equity | 154,684,000 | 147,285,000 | 151,151,000 | 153,142,000 | 155,505,000 | 157,613,000 | 163,875,000 | 57,198,000 | 60,029,000 | 67,707,000 | 79,240,000 | 88,179,000 | 96,138,000 | 101,154,000 | 119,738,000 | 127,080,000 | 63,957,000 | 77,443,000 | 84,377,000 | |||
| total liabilities and stockholders' equity | 269,807,000 | 252,314,000 | 265,309,000 | 260,864,000 | 263,360,000 | 259,587,000 | 269,685,000 | 162,544,000 | 162,721,000 | 143,000,000 | 156,625,000 | 165,531,000 | 168,206,000 | 169,662,000 | 183,828,000 | 187,523,000 | 126,745,000 | |||||
| shares authorized: 5,000,000 at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||
| shares issued and outstanding: none at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||
| shares issued and outstanding: 39,436,634 and 39,165,481 at march 31, 2024 and december 31, 2023, respectively | 39,000 | |||||||||||||||||||||
| restricted cash | 155,000 | 155,000 | 155,000 | 232,000 | 232,000 | 232,000 | 232,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | 310,000 | |||||
| shares authorized: 5,000,000 at december 31, 2023 and 2022 | ||||||||||||||||||||||
| shares issued and outstanding: none at december 31, 2023 and 2022 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at december 31, 2023 and 2022 | ||||||||||||||||||||||
| shares issued and outstanding: 39,165,481 and 38,355,972 at december 31, 2023 and 2022, respectively | 39,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares issued and outstanding: none at september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares issued and outstanding: 38,907,789 and 38,355,972 at september 30, 2023 and december 31, 2022, respectively | 39,000 | |||||||||||||||||||||
| accumulated other comprehensive loss | -284,000 | -331,000 | ||||||||||||||||||||
| shares authorized: 5,000,000 at june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares issued and outstanding: none at june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares issued and outstanding: 38,812,280 and 38,355,972 at june 30, 2023 and december 31, 2022, respectively | 39,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares issued and outstanding: none at march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||
| shares issued and outstanding: 38,708,441 and 38,355,972 at march 31, 2023 and december 31, 2022, respectively | 39,000 | |||||||||||||||||||||
| short-term debt | 9,829,000 | 3,905,000 | ||||||||||||||||||||
| shares authorized: 5,000,000 at december 31, 2022 and 2021 | ||||||||||||||||||||||
| shares issued and outstanding: none at december 31, 2022 and 2021 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at december 31, 2022 and 2021 | ||||||||||||||||||||||
| shares issued and outstanding: 38,355,972 and 34,980,896 at december 31, 2022 and 2021, respectively | 38,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares issued and outstanding: none at september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares issued and outstanding: 35,381,085 and 34,980,896 at september 30, 2022 and december 31, 2021, respectively | 35,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares issued and outstanding: none at june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares issued and outstanding: 35,193,169 and 34,980,896 at june 30, 2022 and december 31, 2021, respectively | 35,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares issued and outstanding: none at march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||
| shares issued and outstanding: 35,073,602 and 34,980,896 at march 31, 2022 and december 31, 2021, respectively | 35,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at december 31, 2021 and 2020 | ||||||||||||||||||||||
| shares issued and outstanding: none at december 31, 2021 and 2020 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at december 31, 2021 and 2020 | ||||||||||||||||||||||
| shares issued and outstanding: 34,980,896 and 34,249,649 at december 31, 2021 and 2020, respectively | 35,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares issued and outstanding: none at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares issued and outstanding: 34,854,822 and 34,249,649 at september 30, 2021 and december 31, 2020, respectively | 35,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares issued and outstanding: none at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares issued and outstanding: 34,623,409 and 34,249,649 at june 30, 2021 and december 31, 2020, respectively | 35,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares issued and outstanding: none at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||
| shares issued and outstanding: 34,438,290 and 34,249,649 at march 31, 2021 and december 31, 2020, respectively | 34,000 | |||||||||||||||||||||
| liabilities and stockholders’ equity | ||||||||||||||||||||||
| stockholders’ equity): | ||||||||||||||||||||||
| shares authorized: 5,000,000 at december 31, 2020 and 2019 | ||||||||||||||||||||||
| shares issued and outstanding: none at december 31, 2020 and 2019 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at december 31, 2020 and 2019 | ||||||||||||||||||||||
| shares issued and outstanding: 34,249,649 and 31,255,267 at december 31, 2020 and 2019, respectively | 34,000 | |||||||||||||||||||||
| total stockholders’ equity | 107,500,000 | 71,891,000 | ||||||||||||||||||||
| total liabilities and stockholders’ equity | 179,314,000 | 137,402,000 | ||||||||||||||||||||
| shares authorized: 5,000,000 at september 30, 2020 and december 31, 2019 | ||||||||||||||||||||||
| shares issued and outstanding: none | ||||||||||||||||||||||
| shares authorized: 100,000,000 at september 30, 2020 and december 31, 2019 | ||||||||||||||||||||||
| shares issued and outstanding: 33,889,077 and 31,255,267 at september 30, 2020 and december 31, 2019, respectively | 34,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at june 30, 2020 and december 31, 2019 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at june 30, 2020 and december 31, 2019 | ||||||||||||||||||||||
| shares issued and outstanding: 33,610,099 and 31,255,267 at june 30, 2020 and december 31, 2019, respectively | 34,000 | |||||||||||||||||||||
| shares authorized: 5,000,000 at march 31, 2020 and december 31, 2019 | ||||||||||||||||||||||
| shares authorized: 100,000,000 at march 31, 2020 and december 31, 2019 | ||||||||||||||||||||||
| shares issued and outstanding: 31,395,637 and 31,255,267 at march 31, 2020 and december 31, 2019, respectively | 31,000 | |||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders’ equity | ||||||||||||||||||||||
| redeemable convertible preferred stock | 31,803,000 | |||||||||||||||||||||
| shares authorized: none and 24,069,615 at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
| shares issued and outstanding: none and 21,233,190 at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
| liquidation preference: none and 121,144 at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
| stockholders’ equity | ||||||||||||||||||||||
| shares authorized: 5,000,000 and none at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
| shares issued and outstanding: none at december 31, 2019 and 2018 | ||||||||||||||||||||||
| shares authorized: 100,000,000 and 29,879,220 at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||
| shares issued and outstanding: 31,255,267 and 1,135,310 at december 31, 2019 and 2018, respectively | 31,000 | |||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders' equity | ||||||||||||||||||||||
| shares authorized: none and 24,069,615 at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| shares issued and outstanding: none and 21,233,190 at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| liquidation preference: none and 121,144 at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| stockholders' equity | ||||||||||||||||||||||
| shares authorized: 5,000,000 and none at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| shares authorized: 100,000,000 and 29,879,220 at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| shares issued and outstanding: 30,775,980 and 1,135,310 at september 30, 2019 and december 31, 2018, respectively | 31,000 | |||||||||||||||||||||
| total liabilities, redeemable convertible preferred stock and stockholders' equity | 138,569,000 | 142,652,000 | ||||||||||||||||||||
| shares authorized: none and 24,069,615 at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| shares issued and outstanding: none and 21,233,190 at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| liquidation preference: none and 121,144 at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| shares authorized: 5,000,000 and none at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| shares authorized: 100,000,000 and 29,879,220 at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| shares issued and outstanding: 30,747,714 and 1,135,310 at june 30, 2019 and december 31, 2018, respectively | 31,000 | |||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders' deficit | ||||||||||||||||||||||
| shares authorized: 24,069,615 at march 31, 2019 and december 31, 2018 | ||||||||||||||||||||||
| shares issued and outstanding: 21,238,105 and 21,233,190 at march 31, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||
| liquidation preference: 121,174 and 121,144 at march 31, 2019 and december 31, 2018, respectively | 105,265,000 | |||||||||||||||||||||
| stockholders' deficit: | ||||||||||||||||||||||
| shares authorized: 29,879,220 at march 31, 2019 and december 31, 2018 | ||||||||||||||||||||||
| shares issued and outstanding: 1,386,615 and 1,135,310 at march 31, 2019 and december 31, 2018, respectively | 1,000 | |||||||||||||||||||||
| total stockholders' deficit | -158,074,000 | |||||||||||||||||||||
| total liabilities, redeemable convertible preferred stock and stockholders' deficit | 38,668,000 |
We provide you with 20 years of balance sheets for Silk Road Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Silk Road Medical. Explore the full financial landscape of Silk Road Medical stock with our expertly curated balance sheets.
The information provided in this report about Silk Road Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.